healthprotocol.wiki

curtis-dj_2025_rct_gvhd-prophylaxis-with-cyclophosphamide-and-cyclosporin

9 findings

Protocol
therapy-post-transplant-cyclophosphamide-cyclosporin-gvhd-prophylaxis-generic
Outcome
biomarker-neutrophil-engraftment-time-days-measured
n
67
effect
0
attribution
85
Protocol
therapy-post-transplant-cyclophosphamide-cyclosporin-gvhd-prophylaxis-generic
Outcome
biomarker-platelet-recovery-time-days-measured
n
67
effect
-10
attribution
85
Protocol
medication-gvhd-prophylaxis-cyclosporine-methotrexate-generic
Outcome
immune-gvhd-acute-grade-3-to-4-incidence-at-3-months-cohort-measured
n
67
effect
-10
attribution
85
Protocol
therapy-post-transplant-cyclophosphamide-cyclosporin-gvhd-prophylaxis-generic
Outcome
immune-gvhd-acute-grade-3-to-4-incidence-at-3-months-cohort-measured
n
67
effect
70
attribution
85
Protocol
therapy-post-transplant-cyclophosphamide-cyclosporin-gvhd-prophylaxis-generic
Outcome
safety-serious-adverse-events-in-first-100-days-count-cohort-measured
n
67
effect
0
attribution
85
Protocol
medication-gvhd-prophylaxis-cyclosporine-methotrexate-generic
Outcome
survival-gvhd-relapse-free-proportion-cohort-measured
n
67
effect
10
attribution
85
Protocol
therapy-post-transplant-cyclophosphamide-cyclosporin-gvhd-prophylaxis-generic
Outcome
survival-gvhd-relapse-free-proportion-cohort-measured
n
67
effect
75
attribution
85
Protocol
medication-gvhd-prophylaxis-cyclosporine-methotrexate-generic
Outcome
survival-overall-at-2-years-proportion-cohort-measured
n
67
effect
0
attribution
85
Protocol
therapy-post-transplant-cyclophosphamide-cyclosporin-gvhd-prophylaxis-generic
Outcome
survival-overall-at-2-years-proportion-cohort-measured
n
67
effect
40
attribution
85